Cargando…
Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
INTRODUCTION: obstetric hemorrhage is estimated to cause 25% of all maternal deaths and is the leading direct cause of maternal mortality worldwide. The World Health Organization recommended the use of uterotonics that should be offered for all women who will give birth but in some countries or in s...
Autores principales: | Zgaya, Rym, Ghadhab, Imen, Triki, Mohamed Amine, Briki, Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467627/ https://www.ncbi.nlm.nih.gov/pubmed/32952830 http://dx.doi.org/10.11604/pamj.2020.36.186.22538 |
Ejemplares similares
-
High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010) -
Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012) -
Breast cancer in men: a serie of 45 cases and literature review
por: Methamem, Marwa, et al.
Publicado: (2020) -
Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
por: Atukunda, Esther C., et al.
Publicado: (2014) -
Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)